Olanzapine: The game-changer “antiemetic”

Chemotherapy-induced nausea and vomiting (CINV) is significantly debilitating and worsens the quality of life. Olanzapine, an atypical antipsychotic drug, also has an antiemetic potential. Studies have shown that olanzapine-based regimens have similar efficacy as compared to aprepitant in patients r...

Full description

Bibliographic Details
Published in:	Indian Journal of Medical and Paediatric Oncology
Main Author:	Manikandan Dhanushkodi
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Subjects:	chemotherapy-induced nausea and vomiting highly emetogenic chemotherapy olanzapine
Online Access:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=274;epage=276;aulast=Dhanushkodi

Similar Items

Olanzapine versus Aprepitant for Prophylaxis of Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Prospective Randomized Study
by: Lakshmi D. Gedela, et al.

Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
by: Akihiro Uchiike, et al.
Published: (2023-08-01)

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide
by: Suehiro M, et al.
Published: (2021-02-01)

Aprepitant versus Olanzapine in Patients of Breast Cancer on Adriamycin and Cyclophosphamide Regimen – Role in Effectiveness of Prevention of Nausea and Vomiting
by: Indrani Devi Sarma, et al.
Published: (2025-06-01)

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials
by: Suguru Kojima, et al.
Published: (2025-10-01)

Adequate antiemetic treatment in patients receiving antitumor drug therapy
by: M. B. Pak, et al.
Published: (2024-08-01)

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023-05-01)

The effect and safety of olanzapine on nausea and vomiting in children receiving moderately emetogenic chemotherapy
by: Aziz Eghbali, et al.
Published: (2023-01-01)

Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy
by: Rudolph M. Navari, et al.
Published: (2018-07-01)

Olanzapine enhances the effect of conventional drugs in chemotherapy induced nausea and vomiting: A randomized clinical trial
by: Atefe Khani, et al.
Published: (2022-02-01)

Olanzapine versus standard antiemetic prophylaxis for the prevention of post-discharge nausea and vomiting after propofol-based general anaesthesia: A randomised controlled trial
by: Binayak Deb, et al.
Published: (2024-05-01)

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
by: So Rae Lee, et al.
Published: (2020-09-01)

Efficacy of antiemetic regimens for prevention and treatment of chemotherapy-induced nausea and vomiting in patients of breast cancer receiving highly emetogenic chemotherapy
by: Soumya Vij, et al.
Published: (2020-01-01)

Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer
by: Xiaozhen Luo, et al.
Published: (2023-09-01)

Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
by: Yi Cheng, et al.
Published: (2022-07-01)

A deep learning‐based interpretable decision tool for predicting high risk of chemotherapy‐induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy
by: Jingyue Zhang, et al.
Published: (2023-09-01)

Effects of the Wrist Band Acupressure Technique on the Severity of Nausea among Patients Receiving Highly Versus Moderately Emetogenic Chemotherapy
by: Zahraa Jasim Alwan, et al.
Published: (2023-08-01)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01)

A study on utilization and evaluation of antiemetics in chemotherapy-induced nausea and vomiting
by: Gayathri Baburaj, et al.
Published: (2017-01-01)

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial
by: Schnadig ID, et al.
Published: (2017-05-01)

Clinical Observation of Olanzapine in Treatment of Nausea and Vomiting Caused by Opioid Analgesics
by: LI Daojun, et al.
Published: (2018-05-01)

Nausea and vomiting induced by pharmacotherapy: have all issues of maintenance therapy been resolved?
by: M. M. Konstantinova, et al.
Published: (2023-06-01)

Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
by: Soumya Simhadri, et al.

Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal
by: António Araújo, et al.
Published: (2023-01-01)

Advancements in managing chemotherapy-induced nausea and vomiting: From efficacy to cost-effectiveness
by: Yuvashree Chandrasekaran, et al.
Published: (2024-06-01)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
by: Zhao Y, et al.
Published: (2021-01-01)

Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials
by: Senri Yamamoto, et al.
Published: (2021-07-01)

Prophylaxis and management of antineoplastic drug induced nausea and vomiting in children with cancer
by: Sidharth Totadri
Published: (2016-10-01)

Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
by: Yeo W, et al.
Published: (2024-04-01)

Comparison of granisetron plus dexamethasone versus an antiemetic cocktail containing midazolam and diphenhydramine for chemotherapy induced nausea and vomiting in children
by: Suna Emir, et al.
Published: (2013-01-01)

Role of ganaton in antiemetic therapy. New treatment capacities
by: A. V. Snegovoy, et al.
Published: (2014-08-01)

Research Progress on the Antiemetic Effect of Traditional Chinese Medicine Against Chemotherapy-Induced Nausea and Vomiting: A Review
by: Yao-Zhong Zhao, et al.
Published: (2022-02-01)

The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients
by: Fanming Kong, et al.
Published: (2022-07-01)

Feasibility of using the Multinational Association of Supportive Care in Cancer antiemesis tool for assessment of chemotherapy-induced nausea and vomiting at Institute for Oncology and Radiology of Serbia and palliative care team
by: Bakić N., et al.
Published: (2015-01-01)

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Kyoko Oura, et al.
Published: (2025-05-01)

Erratum: The clinical observation of acupuncture combined with antiemetic drugs in the prevention and treatment of CINV in breast cancer patients
by: Frontiers Production Office
Published: (2022-10-01)

Medicinal Plants for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Antiemetic, Chemosensitizing, and Immunomodulatory Mechanisms
by: Sun X, et al.
Published: (2025-07-01)

Evaluation of Antiemetic Consistency in Chemotherapy-Induced Nausea and Vomiting Among NHL Patients in Sana’a, Yemen
by: Battah MM, et al.
Published: (2024-05-01)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
by: Cabanillas Stanchi KM, et al.
Published: (2019-09-01)

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
by: Tomohiko Kimura, et al.
Published: (2024-03-01)